https://www.selleckchem.com/products/rk-33.html
46, 1.03-2.08). We identified 2 predictors of graft failure among patients with ACM namely, renal failure requiring dialysis (HR, 5.4, 1.6-17) and previous history of malignancy (HR, 1.6, 1.0-28). Patients with ACM with neither risk factor had 5-year graft survivals of 82%, which is comparable with DCM (HR, 1.28, 0.90-1.91). On the other hand, patients with ACM and either risk factor had worse 5-year graft survivals of 62% (HR, 2.44, 1.39-4.28). Increasing numbers of patients with ACM are undergoing heart transplants. Although patients wi
Like
Comment
Share
